The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders

Nutrients. 2022 Jan 31;14(3):624. doi: 10.3390/nu14030624.

Abstract

The gut microbiota is a complex community of microorganisms that has become a new focus of attention due to its association with numerous human diseases. Research over the last few decades has shown that the gut microbiota plays a considerable role in regulating intestinal homeostasis, and disruption to the microbial community has been linked to chronic disease conditions such as inflammatory bowel disease (IBD), colorectal cancer (CRC), and obesity. Obesity has become a global pandemic, and its prevalence is increasing worldwide mostly in Western countries due to a sedentary lifestyle and consumption of high-fat/high-sugar diets. Obesity-mediated gut microbiota alterations have been associated with the development of IBD and IBD-induced CRC. This review highlights how obesity-associated dysbiosis can lead to the pathogenesis of IBD and CRC with a special focus on mechanisms of altered absorption of short-chain fatty acids (SCFAs).

Keywords: CRC; IBD; SCFAs; gut microbiota; obesity.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Dysbiosis / complications
  • Gastrointestinal Microbiome* / physiology
  • Humans
  • Inflammatory Bowel Diseases* / complications
  • Obesity / complications